SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and social media users closely monitor the company's ticker alongside volatile geopolitical developments in the Middle East. The community is actively debating the potential economic and political consequences of the current administration's foreign policy maneuvers, with discourse heavily polarized between strong institutional support and harsh criticism regarding the potential for wider conflict and regional instability.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is capturing investor interest as a potential acquisition target in the high-stakes obesity market, driven by clinical progress for its muscle-sparing WVE-007 candidate and regained full rights to its AATD therapy, WVE-006. The community is actively discussing the stock's long-term potential as a differentiated RNA-based alternative to traditional GLP-1 treatments, with analysts highlighting these upcoming readouts as key catalysts for a significant valuation rerating.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors remain intensely focused on potential acquisition news and ongoing speculation surrounding the company's long-term capital allocation strategy. The community is actively debating the impact of upcoming warrant expirations and short interest dynamics, while frequently comparing current market conditions to past periods of high volatility.

Superfluid is a revolutionary asset streaming and distribution protocol bringing subscriptions, salaries, vesting, and rewards to DAOs and crypto-native businesses worldwide. This is made possible by the protocol’s smart contract framework which introduces the Super Token - an extension to the ERC-20 standard enabling the transfer of value in completely novel ways.

Superfluid

Superfluid is attracting significant investor attention due to its unusually decentralized holder structure and anticipation of potential exchange listings beyond its current exclusive Coinbase availability. Market participants are actively debating the token's long-term growth prospects, balancing optimism over its decentralized distribution against concerns regarding high volatility and recent price movement.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating significant buzz due to its ultra-low circulating supply, leading the community to discuss its potential for rapid price appreciation and a possible supply shock. Many investors are actively accumulating the token, betting that increased volume will trigger a major breakout for the NFT-focused platform.

Derive is a decentralized protocol that creates programmable onchain options, perpetuals, and structured products.   Derive is deployed and operates on Derive Chain, an Ethereum rollup built using the OP stack and is the home of the Derive Protocol. It is a permission-less smart contract platform.  The Derive DAO earns trading fees from the Derive Protocol and gas fees from the Derive Chain, governed by DRV token holders. Trading fees accrue to an insurance fund to foster robustness of the protocol and rollup.  Derive has built an AI-powered trading app built for pro traders. In collaboration with Messari, Derive Pro translates market views into trades. The agent then prepares transactions for users and leverages smart contract wallets to make trades one-click, gasless and chainless. The app will support spot, perps and options trading on Derive, and will also plug in to spot AMMs on L2s like Optimism, Arbitrum and Base.

Derive

Derive is gaining significant momentum and community attention as investors highlight its ongoing consolidation, recent protocol developments like the Onchain Matrix, and anticipation surrounding upcoming buybacks. Traders are actively discussing the token's technical strength and its strategic partnership with Synthetix, fueling a narrative of long-term growth potential.

Pelican Acquisition Corporation is a special-purpose acquisition company that aims to merge with or acquire businesses, particularly in the global technology sector. The company's primary purpose of facilitate a merger, share exchange, asset acquisition, share purchase, reorganization, or any other form of business combination with one or more businesses.

Greenland Energy Co.

Greenland Energy Co. (GLND) is trending as retail investors speculate on a massive potential oil discovery in the Jameson Land Basin, with community discussions heavily focused on the company's drilling contracts and speculative future price targets. While some bulls are citing long-term energy security and institutional involvement as catalysts for a major surge, skeptics are actively warning about the stock's volatility, potential dilution, and the high-risk nature of speculative Arctic exploration.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is experiencing heightened volatility as traders weigh conflicting geopolitical reports regarding potential de-escalation between the U.S. and Iran against the reality of continued supply disruptions. Community sentiment remains deeply divided, with many participants actively debating whether recent diplomatic commentary is a genuine shift or merely a tactical attempt to manipulate market sentiment and mitigate energy sector concerns.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is trending following a strategic decision to sell over 15,000 Bitcoin to repurchase $1 billion in convertible debt at a discount, a move intended to clean up the balance sheet and reduce future dilution. While community sentiment remains polarized between those viewing this as pragmatic financial discipline and those criticizing the firm for selling assets at a loss, traders are actively monitoring the stock for potential short-squeeze volatility amid high short interest.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors monitor a critical, pending Supreme Court decision regarding patent infringement claims against generic competitors. The conversation is further fueled by anticipation of upcoming preliminary 2025 financial results and high-level business development meetings during the J.P. Morgan Healthcare Conference, as stakeholders weigh potential acquisition catalysts against the company's long-term commercial execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biomea Fusion Details Icovamenib Diabetes Milestones, Teases BMF-650 Obesity Readouts

Executives from Biomea Fusion (NASDAQ:BMEA) discussed the company's lead diabetes program, icovamenib, and outlined near-term clinical milestones during a recent company event hosted by an operator...

Biomea Fusion Teases Q2 Phase 1 Data for Oral GLP-1 BMF-650, Advances Icovamenib in Diabetes

Biomea Fusion (NASDAQ:BMEA) outlined several near-term clinical milestones and development priorities during a JPMorgan conference call, with executives emphasizing upcoming Phase I data for its oral GLP-1 receptor agonist candidate BMF-650 and continued advancement of icovamenib in diabetes.

BMF-6...

Biomea Fusion (NASDAQ:BMEA) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded shares of Biomea Fusion from a "sell" rating to a "hold" rating in a report on Saturday...

Biomea Fusion (NASDAQ:BMEA) Price Target Raised to $7.00 at Citigroup

Citigroup increased their price objective on Biomea Fusion from $6.00 to $7.00 and gave the stock a "buy" rating in a report on Friday...

HC Wainwright Comments on Biomea Fusion Q1 Earnings

Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) - Equities researchers at HC Wainwright issued their Q1 2026 earnings estimates for Biomea Fusion in a research report issued to clients and investors...

Biomea Fusion's (BMEA) Buy Rating Reaffirmed at D. Boral Capital

D. Boral Capital restated a "buy" rating and set a $12.00 target price on shares of Biomea Fusion in a research report on Wednesday...

Biomea Fusion (NASDAQ:BMEA) Issues Quarterly Earnings Results

Biomea Fusion (NASDAQ:BMEA - Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of ($0.25) by...

Biomea Fusion (BMEA) Expected to Announce Quarterly Earnings on Monday

Biomea Fusion (NASDAQ:BMEA) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-biomea-fusion-inc-stock...

Heights Capital Management Inc. Reduces Stock Holdings in Biomea Fusion, Inc. $BMEA

Heights Capital Management Inc. reduced its position in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 62.6% in the 3rd quarter, according to the company in its most recent disclosure...

Biomea Fusion Reports Positive Phase II Data For Diabetes Drug Icovamenib

Biomea Fusion (NASDAQ: BMEA) shares rose Friday after the company reported positive Phase II data for icovamenib in type 2 diabetes, highlighting durable efficacy and a favorable safety profile.read...

This account has been verified as an official BMEA representative.

Verified Account

Biomea Fusion IR

Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in San Carlos, CA.

Biomea Fusion Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

BMEA
Biomea Fusion Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BMEA News

BMEABiomea Fusion Inc